DANIEL JANNEY
CIK 1198325 · last filed 2026-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$30.11M
Companies
11
Total Filings
80
Lifetime Open-Market Net
-$107.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRYS | Director | 74,036 | $341.12 | $25.26M | -$42.01M | 16 | 2026-03-03 |
| Allakos Inc. (ALLK) Delisted | Director | 6,448,053 | $0.33 | $2.12M | $1.22M | 11 | 2023-05-30 |
| ESPR | Director | 48,014 | $3.18 | $152.7K | -$2.73M | 11 | 2021-05-28 |
| STRO | Director | 194,490 | $24.17 | $4.70M | $0 | 3 | 2019-06-19 |
| VIVEVE MEDICAL, INC. (VIVE) Delisted | Director | 1,443 | $0.00 | $0 | $3.00M | 16 | 2019-01-02 |
| VIVEVE MEDICAL, INC. (TCON) Delisted | Director | 27,278 | $0.03 | $878 | $1.60M | 4 | 2016-01-29 |
| Evofem Biosciences, Inc. (NEOT) Delisted | Director | 264,963 | — | — | -$6.01M | 2 | 2015-12-30 |
| ZS Pharma, Inc. (ZSPH) Delisted | 10%+ Owner | 2,646,643 | — | — | -$50.75M | 1 | 2015-06-09 |
| ELLIE MAE INC (ELLI) Delisted | 10%+ Owner | 3,364,708 | — | — | -$11.77M | 1 | 2011-04-21 |
| ANESIVA, INC. (ANSV) Delisted | Director | 6,172,840 | — | — | $0 | 3 | 2008-05-12 |
| COTHERIX INC (CTRX) Delisted | Director | — | — | — | $0 | 1 | 2007-01-05 |
Recent Filings · Page 6 of 8
80 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-09-25 | KRYS | Mixed | +324,456 | $2.00M | EDGAR |
| 2017-09-08 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | +3,025 | $0 | EDGAR |
| 2017-05-19 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | +2,387 | $0 | EDGAR |
| 2017-05-19 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | +2,387 | $0 | EDGAR |
| 2017-04-19 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2017-03-23 | ESPR | Sell (S) | −350,000 | -$16.03M | EDGAR |
| 2017-03-21 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Buy (P) | +500,000 | $2.00M | EDGAR |
| 2016-12-28 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-14 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | +1,775 | $0 | EDGAR |
| 2016-08-24 | VIVEVE MEDICAL, INC. (VIVE) Delisted | Grant (A) | +1,279 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.